All Antibody articles
-
-
Research
Small molecule finds flu virus’s weak spot
Drug candidate that targets highly conserved region of virus gave mice complete protection from swine flu
-
Research
Forceful treatment stabilises drug antibody linkages
Ultrasonic energy could modify maleimide–thiol connections in cancer treatments in volume
-
News
What is directed evolution and why did it win the chemistry Nobel prize?
If you’ve got questions about yesterday’s chemistry Nobel prize then we’ve got answers
-
News
Vaccines central to efforts to head off latest Ebola outbreak
Ring vaccination strategy could halt disease in its tracks provided health systems can cope
-
Opinion
Rise of the biologics
Antibodies, RNA and gene therapy don’t necessarily compete with small molecule drugs – and they all rely on chemistry
-
Business
Amgen partners to launch biosimilars in China
US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
-
Business
AstraZeneca shares tumble after antibody failure
Imfinzi and tremelimumab checkpoint inhibitor pairing fails to beat chemotherapy in lung cancer
-
Business
Celgene and BeiGene agree cancer partnership
Immuno-oncology deal sees firms exchange licensing rights for antibody drugs
-
Business
Seattle Genetics cancels Immunomedics deal
Settlement also resolves disputes with shareholders
-
Business
Cholesterol drug withdrawn in patent dispute
Ruling that Regeneron’s Praluent antibody infringes Amgen’s Repatha patent could stifle innovation
-
Business
Standard antibody will bolster biopharma
New NIST reference material will help validate and compare analytical techniques
-
Business
AstraZeneca licenses skin drugs to Leo
Offloading psoriasis and dermatitis antibodies continues AZ’s plan to refocus on fewer therapy areas
-
Business
Novartis partners with Xencor for cancer antibodies
Deal deepens Novartis’s focus on immuno-oncology
-
Business
BioAtla and Pfizer to collaborate on antibody research
Two-way agreement to share technology and royalties on new cancer drugs
-
-
Business
Amgen seeks injunction to protect patents
Sanofi and Regeneron sued over cholesterol-regulating antibodies
-
News
Doctors turn to experimental Ebola treatments
Drugs and vaccines untested in humans are being trialled on Ebola patients
-
Business
Merck & Co doubles up on Ablynx research deal
Cancer nanobody R&D partnership could be worth €1.7 billion
